Published in J Thromb Haemost on October 23, 2009
The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles. J Thromb Haemost (2013) 1.68
von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood (2013) 1.17
Alloantibodies in von Willebrand disease. Blood (2013) 0.96
Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals. Haemophilia (2013) 0.77
Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients. PLoS One (2014) 0.76
Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism. Blood (2016) 0.75
Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity. Int J Lab Hematol (2012) 0.75
Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand's disease. Exp Ther Med (2016) 0.75
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood (2016) 0.75
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost (2006) 2.57
Combined effect of infection and heavy wrapping on the risk of sudden unexpected infant death. Arch Dis Child (1992) 2.49
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
Complete primary structure of human and rabbit lactase-phlorizin hydrolase: implications for biosynthesis, membrane anchoring and evolution of the enzyme. EMBO J (1988) 2.21
RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev (1994) 2.17
Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide". J Biol Chem (1989) 1.96
Overview of research on women in medicine--issues for public policymakers. Public Health Rep (1986) 1.90
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Assessing performance-related disability in patients with knee osteoarthritis. Osteoarthritis Cartilage (1995) 1.80
Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy. Histopathology (2008) 1.78
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain. J Thromb Haemost (2006) 1.75
Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health (1991) 1.71
The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles. J Thromb Haemost (2013) 1.68
Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci U S A (1991) 1.65
ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost (2010) 1.64
Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost (2003) 1.64
Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost (2008) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
The prevention of skin excoriation under children's hip spica casts using the goretex pantaloon. J Pediatr Orthop (1995) 1.57
Lower rates of dislocation with increased femoral head size after primary total hip replacement: a five-year analysis of NHS patients in England. J Bone Joint Surg Br (2011) 1.52
Epidemiology of Encephalitis: Western Equine Type, Manitoba, 1941. Can Med Assoc J (1942) 1.45
A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers. J Thromb Haemost (2004) 1.45
Direct detection of a common inversion mutation in the genetic diagnosis of severe hemophilia A. Blood (1994) 1.43
Bilateral, sequential rupture of the patellar tendon in systemic lupus erythematosus. A case report. J Bone Joint Surg Am (1974) 1.39
Structural requirements for the carbohydrate ligand of E-selectin. Proc Natl Acad Sci U S A (1991) 1.39
Physical functioning and mental health in patients with chronic medical conditions. Qual Life Res (1999) 1.38
The evaluation of pain in patients with knee osteoarthritis: the knee pain scale. J Rheumatol (1995) 1.32
Wait times for gastroenterology consultation in Canada: the patients' perspective. Can J Gastroenterol (2010) 1.31
'Failure to rescue' as a measure of quality of hospital care: the limitations of secondary diagnosis coding in English hospital data. J Public Health Med (1999) 1.30
A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B. Br J Haematol (1990) 1.29
The calmodulin binding domain of the plasma membrane Ca2+ pump interacts both with calmodulin and with another part of the pump. J Biol Chem (1989) 1.28
SSI1 encodes a novel Hsp70 of the Saccharomyces cerevisiae endoplasmic reticulum. Mol Cell Biol (1996) 1.27
Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane. J Biol Chem (1990) 1.26
Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost (2009) 1.24
Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay. Blood (1979) 1.22
Purification and characterization of the arylsulfatase synthesized by Pseudomonas aeruginosa PAO during growth in sulfate-free medium and cloning of the arylsulfatase gene (atsA). Eur J Biochem (1995) 1.22
Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost (2010) 1.21
Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol (1998) 1.20
The yeast hsp70 homologue Ssa is required for translation and interacts with Sis1 and Pab1 on translating ribosomes. J Biol Chem (2001) 1.19
Theory in a practice discipline. I. Practice oriented discipline. Nurs Res (1968) 1.19
Characterization of the Net1 cell cycle-dependent regulator of the Cdc14 phosphatase from budding yeast. J Biol Chem (2001) 1.19
From one gene to two proteins: the biogenesis of cytochromes b and c1 in Bradyrhizobium japonicum. Proc Natl Acad Sci U S A (1991) 1.17
The cold sensitivity of a mutant of Saccharomyces cerevisiae lacking a mitochondrial heat shock protein 70 is suppressed by loss of mitochondrial DNA. J Cell Biol (1996) 1.17
Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci (1996) 1.14
Quantitation and facilitated de novo sequencing of proteins by isotopic N-terminal labeling of peptides with a fragmentation-directing moiety. Anal Chem (2000) 1.13
Home management of haemophilia. Haemophilia (2004) 1.12
Interaction of calmodulin with the calmodulin binding domain of the plasma membrane Ca2+ pump. Biochemistry (1990) 1.11
Analysis of global responses by protein and peptide fingerprinting of proteins isolated by two-dimensional gel electrophoresis. Application to the sulfate-starvation response of Escherichia coli. Eur J Biochem (1996) 1.10
Involvement of products of the nrfEFG genes in the covalent attachment of haem c to a novel cysteine-lysine motif in the cytochrome c552 nitrite reductase from Escherichia coli. Mol Microbiol (1998) 1.09
Current status of haemophilia gene therapy. Haemophilia (2014) 1.09
The molecular mechanisms of immunomodulation and tolerance induction to factor VIII. J Thromb Haemost (2009) 1.09
Health-related quality of life among final-year medical students. CMAJ (2000) 1.08
Molecular features underlying the sequential phosphorylation of HS1 protein and its association with c-Fgr protein-tyrosine kinase. J Biol Chem (1999) 1.08
The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease. J Thromb Haemost (2007) 1.08
Using simulated patients to train physicians in sexual risk assessment and risk reduction. Acad Med (1990) 1.07
GRP94 (endoplasmin) co-purifies with and is phosphorylated by Golgi apparatus casein kinase. FEBS Lett (2000) 1.07
The canine factor VIII cDNA and 5' flanking sequence. Thromb Haemost (1998) 1.06
Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment. J Thromb Haemost (2007) 1.06
Dysautonomia among patients with fibromyalgia: a noninvasive assessment. J Rheumatol (2000) 1.06
The Factor VIII acute phase response requires the participation of NFkappaB and C/EBP. Thromb Haemost (2000) 1.06
The ssu locus plays a key role in organosulfur metabolism in Pseudomonas putida S-313. J Bacteriol (2000) 1.05
The MAS-encoded processing protease of yeast mitochondria. Interaction of the purified enzyme with signal peptides and a purified precursor protein. J Biol Chem (1991) 1.05
Dual arterial supply to normal lung: within the sequestration spectrum. Br J Radiol (2010) 1.05
Mapping of functional domains in the plasma membrane Ca2+ pump using trypsin proteolysis. Biochemistry (1990) 1.04
Triterpene glycosides from Cimicifuga racemosa. J Nat Prod (2000) 1.04
A nuclear export signal prevents Saccharomyces cerevisiae Hsp70 Ssb1p from stimulating nuclear localization signal-directed nuclear transport. J Biol Chem (1999) 1.04
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost (2000) 1.03
A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol (2000) 1.02
Proteome mapping, mass spectrometric sequencing and reverse transcription-PCR for characterization of the sulfate starvation-induced response in Pseudomonas aeruginosa PAO1. Eur J Biochem (1999) 1.02
Proteomics and automation. Electrophoresis (1999) 1.02
Developmental regulation of cytokeratins in cells of the rat mammary gland studied with monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 1.02
Critical loads and steady-state chemistry for streams in the state of Maryland. Environ Pollut (1992) 1.02
Results and complications of adductor tenotomy and obturator neurectomy in cerebral palsy. Clin Orthop Relat Res (1968) 1.02
Access to care in regionalized health care systems. JAMA (1996) 1.01
Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule. FEBS Lett (1979) 1.01
Epithelial cell types and their evolution in the rat mammary gland determined by immunological markers. Proc Natl Acad Sci U S A (1983) 1.01
PVC--as flooring material--and its association with incident asthma in a Swedish child cohort study. Indoor Air (2010) 1.00
Single amino acid substitutions can convert the uncleaved signal-anchor of sucrase-isomaltase to a cleaved signal sequence. J Biol Chem (1992) 1.00
Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres. Curr Oncol (2011) 1.00
Functional changes of intermediate filaments in fibroblastic cells revealed by a monoclonal antibody. Proc Natl Acad Sci U S A (1983) 0.99
Primary care physicians' assessment and prevention of HIV infection. Am J Prev Med (1989) 0.98
Does bariatric surgery prior to lower limb joint replacement reduce complications? Surgeon (2010) 0.98
Mitochondrial creatine kinase from chicken brain. Purification, biophysical characterization, and generation of heterodimeric and heterooctameric molecules with subunits of other creatine kinase isoenzymes. J Biol Chem (1990) 0.98
von Willebrand disease update: diagnostic and treatment dilemmas. Haemophilia (2008) 0.97
Characterization of three soluble c-type cytochromes isolated from soybean root nodule bacteroids of Bradyrhizobium japonicum strain CC705. FEMS Microbiol Lett (1991) 0.97
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells. J Thromb Haemost (2008) 0.97